NCT06529731: Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- State
- Under way
- Phase
- Phase 2
- People
- 57 planned
- Started
- 23 Sep 2024
- Primary completion
- 31 Oct 2029
- Arms
- Cohort 1: IFN-γ + DLI (HLA-matched donor alloSCT recipient cohort), Cohort 2: IFN-γ + DLI (Haploidentical donor alloSCT recipient cohort)
- Results
- None posted
- 31 Jul 2024: Trial registered
- 23 Sep 2024: Trial started